579 results
Page 15 of 29
6-K
EX-99.1
fbx2 jjbk5wwr7c0
26 Oct 12
Teva Receives Approval for Synribotm(omacetaxine Mepesuccinate) for Injection
12:00am
6-K
EX-99.1
y6e 9pgpi
22 Oct 12
PHASE IIa LAQUINIMOD TRIAL RESULTS SHOW POSITIVE DATA FOR POTENTIAL USE IN ACTIVE CROHN’S DISEASE
12:00am
6-K
EX-99.1
7uud1ur82
18 Oct 12
Teva Completes First Year of Shipments of Adenovirus Vaccine to the United States Military
12:00am
6-K
EX-99.1
b4nybgyod8 q9gbxm4
10 Oct 12
Teva to Present Positive Data for Glatiramer Acetate 40 MG/1 ML Given Three Times Weekly for Relapsing-remitting Multiple Sclerosis
12:00am
6-K
EX-99.1
l6hqplj9pq8g
10 Oct 12
New Data Presented at the 28TH Ectrims Congress Showcase Teva’s Ongoing Commitment to Multiple Sclerosis Research
12:00am
6-K
EX-99.1
b2qg737vyxxk
27 Sep 12
Drug candidate to be assessed for managing voluntary motor disturbances in Huntington disease
12:00am
6-K
EX-99.1
b923 3tjg0vfpek6g8q
17 Sep 12
Bayer HealthCare to acquire U.S. animal health business from Teva Pharmaceutical Industries
12:00am
6-K
EX-99.99
kas ebincqvdo
13 Sep 12
Live Filing
12:00am
6-K
EX-99.1
yvd93n
30 Aug 12
Teva Announces Fda Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-induced Neutropenia
12:00am
6-K
EX-99.1
a41gvfnh2c35jqzb0
17 Aug 12
Teva Announces Launch of Generic ACTOplusmet® in the United States
12:00am
6-K
EX-99.1
gi1syb989y1pb e32
17 Aug 12
Teva Announces Launch of Generic Actos® in the United States
12:00am
6-K
EX-99.1
00hm hm2hag
8 Aug 12
Teva to Initiate Third Phase Iii Trial of Oral Laquinimod for the Treatment of Relapsing Remitting Multiple Sclerosis
12:00am
6-K
9np3rn p75yiye
8 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
5hbb 5qvtuab
6 Aug 12
Live Filing
12:00am
6-K
EX-99.1
y0zrbqppwxvg10du273m
6 Aug 12
Teva Reports Second Quarter 2012 Results
12:00am
6-K
cv8hz 4qsn1gx8
2 Aug 12
Current report (foreign)
12:00am
6-K
EX-99.1
aqn4a3nateu1y6kut
2 Aug 12
Teva Updates Dividend Payment Date
12:00am
6-K
EX-99.1
6saocoq35
2 Jul 12
Teva Announces Progress of Biologic Investigational Drugs Evaluated to Treat Neutropenia In Breast Cancer Patients Undergoing Chemotherapy
12:00am
6-K
EX-99.1
l0oevnfx
21 Jun 12
Teva Announces Launch of Generic Symbyax® in the United States
12:00am
6-K
EX-99.1
z2l2ygulkxitt yer
19 Jun 12
Live Filing
12:00am